Structure |
Chemical Name |
CAS |
MF |
 |
2-クロロ-1-(4,5-ジクロロ-2-チエニル)エタン-1-オン |
64218-50-4 |
C6H3Cl3OS |
 |
(5Z,7E)-9,10-セコ-26,27-シクロ-1α,3β-ジヒドロキシコレスタ-5,7,10(19)-トリエン-24-オン |
126860-84-2 |
C27H40O3 |
![(S)-7-アセチルアミノ-6,7-ジヒドロ-3-ヒドロキシ-1,2,10-トリメトキシベンゾ[a]ヘプタレン-9(5H)-オン](/CAS/GIF/7336-33-6.gif) |
(S)-7-アセチルアミノ-6,7-ジヒドロ-3-ヒドロキシ-1,2,10-トリメトキシベンゾ[a]ヘプタレン-9(5H)-オン |
7336-33-6 |
C21H23NO6 |
![2-[4-(4-クロロベンゾイル)フェノキシ]-2-メチルプロパン酸メチル](/CAS/GIF/42019-07-8.gif) |
2-[4-(4-クロロベンゾイル)フェノキシ]-2-メチルプロパン酸メチル |
42019-07-8 |
C18H17ClO4 |
 |
1,3-ジメチル-5,5-ジ(2-プロペニル)ピリミジン-2,4,6(1H,3H,5H)-トリオン |
722-97-4 |
C12H16N2O3 |
![9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-ジヒドロキシ-5β-[(2E,4S,5S)-5-ヒドロキシ-4-メチル-2-ヘキセニル]テトラヒドロ-2H-ピラン]-2β-イル]-3-メチル-2-ブテノイル]オキシ]ノナン酸](/CAS/20210111/GIF/71980-98-8.gif) |
9-[[(2E)-4-[[(2S,3R,4R,5S)-3α,4α-ジヒドロキシ-5β-[(2E,4S,5S)-5-ヒドロキシ-4-メチル-2-ヘキセニル]テトラヒドロ-2H-ピラン]-2β-イル]-3-メチル-2-ブテノイル]オキシ]ノナン酸 |
71980-98-8 |
C26H44O8 |
 |
D,L-O-DesMethyl Venlafaxine-d6 |
1062605-69-9 |
C16H19D6NO2 |
![(E)-3-[p-ブロモメチルフェニル]アクリル酸エチル](/CAS/GIF/78712-67-1.gif) |
(E)-3-[p-ブロモメチルフェニル]アクリル酸エチル |
78712-67-1 |
C12H13BrO2 |
 |
3-アミノ-2-ブテン酸 |
21112-45-8 |
C4H7NO2 |
![7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸](/CAS/GIF/127199-06-8.gif) |
7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプト-5-イル]-8-クロロ-6-フルオロ-1-[(1S,2R)-2-フルオロシクロプロピル]-1,4-ジヒドロ-4-オキソ-3-キノリンカルボン酸 |
127199-06-8 |
C19H18ClF2N3O3 |
![rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine](/CAS/GIF/58827-68-2.gif) |
rac 4-[4-(Oxiranylmethoxy)-1,2,5-thiadiazol-3-yl]morpholine |
58827-68-2 |
C9H13N3O3S |
 |
rac a-Hydroxy Ibuprofen |
60057-62-7 |
C13H18O3 |
![3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one](/CAS/GIF/171967-74-1.gif) |
3a,7a-dihydroxy-5-(1-methyl-1H-indole-3-carbonyl)-hexahydro-1H-benzo[d]imidazol-2(3H)-one |
171967-74-1 |
C17H19N3O4 |
![5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one](/CAS/GIF/139756-31-3.gif) |
5-(5-Chlorosulfonyl-2-ethoxyphenyl)-3-propyl-1,6-dihydro_x000b_-7H-pyrazolo[4,3-d]pyrimidin-7-one |
139756-31-3 |
C16H17ClN4O4S |
 |
5,7-ジフルオロクロマン-4-オン |
844648-22-2 |
C9H6F2O2 |
![(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/769908-13-6.gif) |
(3R,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
769908-13-6 |
C25H24FNO4 |
![(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate](/CAS/20180808/GIF/261506-24-5.gif) |
(7a,17b)-7-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
261506-24-5 |
C34H49F5O4S |
 |
EthanediaMide iMpurity D |
480452-36-6 |
C21H30ClN5O5 |
![N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide](/CAS/20150408/GIF/168626-93-5.gif) |
N-(4-(2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine-6-carbonyl)phenyl)-[1,1'-biphenyl]-2-carboxaMide |
168626-93-5 |
C32H25N3O3 |
 |
Methyl (4-Methylpiperidin-3-yl)carbaMate |
1204176-45-3 |
C8H16N2O2 |
 |
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran |
915095-90-8 |
C17H16BrClO2 |
 |
(2S,3R,4S,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)Methyl)-4-Methylphenyl)-tetrahydro-6-(hydroxyMethyl)-2-Methoxy-2H-pyran-3,4,5-triol |
1358581-37-9 |
C25H27FO6S |
 |
Levocarnitine iMpurity |
6490-20-6 |
C7H17ClN2O2 |
 |
3-Hydroxy-4-Methyl-2(5H)-thiophenone |
34876-35-2 |
C5H6O2S |
![(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid](/CAS/GIF/1048973-04-1.gif) |
(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid |
1048973-04-1 |
C24H34O5 |
 |
(6α)-17,21-Dihydroxy-6-Methylpregna-1,4,9(11)-triene-3,20-dione |
93269-35-3 |
C22H28O4 |
![[N(Z)]-N-(3,5-ジメチル-2(3H)-チアゾリリデン)-4-ヒドロキシ-2-メチル-2H-1,2-ベンゾチアジン-3-カルボキサミド1,1-ジオキシド](/CAS/GIF/1262333-25-4.gif) |
[N(Z)]-N-(3,5-ジメチル-2(3H)-チアゾリリデン)-4-ヒドロキシ-2-メチル-2H-1,2-ベンゾチアジン-3-カルボキサミド1,1-ジオキシド |
1262333-25-4 |
C15H15N3O4S2 |
![1,2-ビス[2-(4-ジベンゾ[B,F][1,4]チアゼピン-11-イル-1-ピペラジニル)エトキシ]エタン](/CAS/GIF/1371638-05-9.gif) |
1,2-ビス[2-(4-ジベンゾ[B,F][1,4]チアゼピン-11-イル-1-ピペラジニル)エトキシ]エタン |
1371638-05-9 |
C40H44N6O2S2 |
![2-[3-カルボキシ-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸](/CAS/GIF/1239233-87-4.gif) |
2-[3-カルボキシ-4-(2-メチルプロポキシ)フェニル]-4-メチル-5-チアゾールカルボン酸 |
1239233-87-4 |
C16H17NO5S |
 |
4-(2-メチルプロピル)ベンゼンエタノール |
36039-35-7 |
C12H18O |
 |
Dasatinib DiMeric IMpurity |
910297-61-9 |
C36H34Cl2N12O2S2 |
 |
Decarboxy Fexofenadine |
185066-37-9 |
C31H39NO2 |
 |
Methotrexate α-Methyl Ester |
66147-29-3 |
C21H24N8O5 |
 |
17- Phenyl Trinor Prostaglandin F2α Methyl Amide |
155206-01-2 |
C24H35NO4 |
 |
ベンダマスチンデスクロロ二量體不純物 |
1391052-61-1 |
C32H44N6O7 |
 |
(2R,3R)-3-アミノ-2-ヒドロキシ-3-フェニルプロパン酸メチル |
157722-44-6 |
C10H13NO3 |
 |
Benzenebutanoicacid,b-aMino-2,4,5-trifluoro-,Methylester,(bR)- |
881995-69-3 |
C11H12F3NO2 |
 |
Bisoprolol IMpurity |
2226263-67-6 |
C18H31NO4 |
 |
Decitabine iMpurity 5 |
|
|
 |
N-(3-ブロモフェニル)-6,7-ビス(2-メトキシエトキシ)-4-キナゾリンアミン |
328528-74-1 |
C20H22BrN3O4 |
 |
LevetiracetaM IMpurity 3 |
1543353-92-9 |
C8H15NO4 |
![(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル](/CAS/20150408/GIF/204254-94-4.gif) |
(3R,4R,5R)-4-(1-エチルプロポキシ)-3-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-94-4 |
C15H26O7S |
 |
9,11-Anhydrobudesonide |
313474-58-7 |
C25H32O5 |
![iperazineacetic acid, 4-[(4- chlorophenyl)phenylMethyl]-](/CAS/20211123/GIF/113740-61-7.gif) |
iperazineacetic acid, 4-[(4- chlorophenyl)phenylMethyl]- |
113740-61-7 |
C19H21ClN2O2 |
 |
エベロリムス-D4 |
1338452-54-2 |
C53H79D4NO14 |
 |
(2R,3R,4R,5R)-5-(4-benzaMido-2-oxopyriMidin-1(2H)-yl)-2-((benzoyloxy)Methyl)-4-chloro-4-Methyltetrahydrofuran-3-yl benzoate |
1496551-70-2 |
C31H26ClN3O7 |
 |
1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione |
114262-49-6 |
C10H14N2O6 |
 |
4-(4-(3-(4-chloro-3-(trifluoroMethyl)phenyl)ureido)-3-fluorophenoxy)-2-(MethylcarbaMoyl)pyridine 1-oxide |
835621-11-9 |
C21H15ClF4N4O4 |
 |
Sch-51048 |
161532-65-6 |
C37H42F2N8O3 |
![1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one](/CAS/20150408/GIF/186521-85-7.gif) |
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-one |
186521-85-7 |
C15H19ClO |
 |
NSC 351869 |
31350-27-3 |
C14H14N2O4 |
 |
N-(1-エチルピロリジン-2-イルメチル)-4-アミノ-5-ヨード-2-メトキシベンズアミド |
176849-91-5 |
C15H22IN3O2 |
![N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride](/CAS/20180808/GIF/63434-11-7.gif) |
N,N'-Vis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethyl-1,3-propanediamine dihydrochloride |
63434-11-7 |
C25H39ClN2O4 |
![(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol](/CAS/20180808/GIF/915095-96-4.gif) |
(3R,4S,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)-2-methoxyoxane-3,4,5-triol |
915095-96-4 |
C24H29ClO8 |
 |
Doxorubicin Imp B HBr salt |
148218-14-8 |
C29H35Br2NO11 |
 |
(R)-2-(Boc-aMino)-2-phenylethyl 4-Methylbenzenesulfonate |
126610-77-3 |
C20H25NO5S |
 |
(2R,3R,4R,5S)-5-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-2-(2-hydroxyethyl)tetrahydrofuran-2,3,4-triol |
|
C23H27ClO7 |
![Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:)](/CAS/20211123/GIF/571189-66-7.gif) |
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:) |
571189-66-7 |
C22H28ClN7O |
 |
Olaparib iMpurity |
|
|
 |
(2S,3R,4R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-5-((S)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol |
|
C21H25ClO6 |
 |
(R)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl) butanoate .(R)-2-hydroxy-2-phenylacetate |
1253055-94-5 |
C19H20F3NO5 |
 |
Olaparib iMpurity A |
|
|
![N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine](/CAS/GIF/1252883-90-1.gif) |
N-((3S,4S)-1-benzyl-4-Methylpiperidin-3-yl)-N-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
1252883-90-1 |
C20H25N5 |
 |
P219490 |
937370-10-0 |
C20H21N5Na2O6** |
 |
(S)-4-(TERT-ブチルトキシ)-2-イソプロピル-4-オキソブタン酸 |
134807-43-5 |
C11H20O4 |
![2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide](/CAS/20180808/GIF/1422284-16-9.gif) |
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1-ethyl 9-(1-Methylethyl) ester, 5-oxide |
1422284-16-9 |
C18H28N5O10P |
![(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol](/CAS/20180808/GIF/156453-53-1.gif) |
(R)-α-[2-(1-naphthalenyloxy)ethyl]-benzeneMethanol |
156453-53-1 |
C19H18O2 |
![(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol](/CAS/20150408/GIF/CB72664140.gif) |
(1S,2S,3R,5S)-3-(7-((1S,2R)-2-(3,4-difluorophenyl)cyclopropylaMino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyriMidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
2096989-56-7 |
C23H28F2N6O4S |
 |
Fosaprepitant iMpurity |
|
|
 |
bortezoMib iMpurity F |
|
|
 |
cefoxitin iMpurity A |
|
|
 |
3-Morpholinone, 4-(2-aMinophenyl)- |
1082588-73-5 |
C10H12N2O2 |
 |
(R)-N-(1-(naphthalen-1-yl)ethyl)-3-(4-(trifluoroMethyl)phenyl)propan-1-aMine |
1428185-71-0 |
C22H22F3N |
![1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-](/CAS/20180808/GIF/344418-92-4.gif) |
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- |
344418-92-4 |
C16H20N6O |
 |
Erlotinib impurity A |
183321-85-9 |
C21H20ClN3O3 |
![1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-](/CAS/20150408/GIF/213699-53-7.gif) |
1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl- |
213699-53-7 |
C15H17NO6 |
 |
Budesonide iMpurity |
192057-49-1 |
C24H32O6 |
 |
dextroMethorphan iMpurity |
|
|
 |
Fluticasone IMpurity |
397864-58-3 |
C27H30F2O6S |
 |
Valdecoxib iMpurity |
|
|
 |
Fluconazole IMpurity-H |
|
|
 |
Retigabine Dihydrochloride Impurity |
1432063-93-8 |
C16H19ClFN3O2 |
 |
Adrenaline IMpurity F |
78995-75-2 |
C9H13NO5S |
 |
AztreonaM IMpurity D |
|
|
 |
メタンスルフィン酸4-メタンスルホニルオキシブタニル |
1797106-48-9 |
C6H14O5S2 |
 |
Deferasirox Ethyl Ester |
201530-79-2 |
C23H19N3O4 |
 |
MetoclopraMide IMpurity F |
38339-95-6 |
C13H20ClN3O2 |
 |
Metronidazole IMpurity E |
|
|
 |
Propofol IMpurity H |
|
|
 |
R-(-)-O-DesMethyl-Venlafaxine-d6 |
1062609-96-4 |
C16H25NO2 |
 |
Ribavirin IMp. C (EP) |
|
|
 |
SalMeterol IMpurity B |
|
C25H37NO4 |
 |
Sitagliptin N-Phoshate IMpurity |
1351498-25-3 |
C16H16F6N5O4P |
 |
SulbactaM IMpurity E |
|
|
 |
TriMethopriM IMpurity A |
213745-86-9 |
C15H20N4O3 |
 |
Varenicline Metadinitro IMpurity |
|
|
 |
1-(4-メトキシフェニル)-2-メチルプロパン-2-アミン |
56490-94-9 |
C11H17NO |
![2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine](/CAS/20150408/GIF/877858-27-0.gif) |
2-Methyl-5,6-dihydro-4H-benzo[b]oxazolo[5,4-d]azepine |
877858-27-0 |
C12H12N2O |
 |
1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-α-D-ribofuranose |
704916-12-1 |
C26H21FO7 |
 |
rac-(3R*)-3-(4-クロロフェニル)-N,N-ジメチル-3-(2-ピリジニル)プロパン-1-アミン |
78539-96-5 |
C16H19ClN2 |